Position in ASND
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,780,205
+$203,722 QoQ
Shares Held
7,783
+5.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Crossmark Global Holdings, Inc. holds $39,668,975 across 33 Biotechnology names. ASND ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
83,415 | $7,851,019 | |
| 2 | ARGX |
Argenx SE
|
8,668 | $6,329,807 | |
| 3 | EXEL |
Exelixis, Inc.
|
79,230 | $3,398,174 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
51,090 | $2,886,074 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
7,661 | $2,275,087 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
7,783 | $1,780,205 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
6,534 | $1,235,252 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,704 | $1,207,444 |
All Filings in ASND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,780,205 | 7,783 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,576,483 | 7,393 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $972,976 | 4,894 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $926,516 | 5,368 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $911,469 | 5,848 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,436,586 | 10,435 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,212,396 | 8,120 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||